Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 73 13
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 6 5
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Dec/17/2020 10 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2020 26 3
Remdesivir Approved by FDA Experimental Antiviral Dec/02/2020 48 4
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 9 1
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 7 0
Tenofovir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 3 3
Emtricitabine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/29/2020 1 2
Imatinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020 4 0